| AstraZeneca PLC (AZN) |
GB |
$213.397B |
15.93 |
| Amgen Inc. (AMGN) |
US |
$146.477B |
13.12 |
| Gilead Sciences, Inc. (GILD) |
US |
$127.503B |
13.24 |
| Vertex Pharmaceuticals (VRTX) |
United States |
$112.644B |
0.00 |
| Bristol Myers Squibb Company (BMY) |
US |
$95.140B |
6.37 |
| GSK PLC Sponsored ADR (GSK) |
GB |
$77.660B |
9.23 |
| CSL Limited Sponsored ADR (CSLLY) |
AU |
$75.159B |
0.00 |
| Regeneron Pharmaceuticals (REGN) |
United States |
$64.166B |
15.57 |
| Alnylam Pharmaceuticals, Inc. (ALNY) |
US |
$37.201B |
0.00 |
| argenex SE (ARGX) |
NL |
$34.537B |
94.27 |
| BeiGene (ONC) |
Cayman Islands |
$22.620B |
0.00 |
| BioNTech SE Sponsored ADR (BNTX) |
DE |
$22.301B |
0.00 |
| Royalty Pharma (RPRX) |
United States |
$19.611B |
8.08 |
| Biogen Inc. (BIIB) |
US |
$18.402B |
7.94 |
| Illumina, Inc. (ILMN) |
US |
$13.237B |
25.11 |
| Genmab A/S Sponsored ADR (GMAB) |
DK |
$12.747B |
14.30 |
| Genmab A/S (GNMSF) |
DK |
$12.475B |
12.76 |
| Insmed, Inc. (INSM) |
US |
$12.407B |
0.00 |
| Exelixis, Inc. (EXEL) |
US |
$12.381B |
21.02 |
| Incyte Corporation (INCY) |
US |
$12.255B |
93.10 |
| BioMarin Pharmaceutical Inc. (BMRN) |
US |
$11.367B |
18.46 |
| Swedish Orphan Biovitrum (BIOVF) |
SE |
$10.858B |
27.73 |
| Exact Sciences Corporation (EXAS) |
US |
$10.643B |
0.00 |
| Moderna, Inc. (MRNA) |
US |
$9.614B |
0.00 |
| Ascendis Pharma A/S (ASND) |
DK |
$9.609B |
0.00 |
| QIAGEN (QGEN) |
Netherlands |
$9.481B |
18.45 |
| Bio-Techne Corp (TECH) |
United States |
$7.705B |
28.74 |
| Roivant Sciences (ROIV) |
United Kingdom |
$7.699B |
0.00 |
| Revolution Medicines (RVMD) |
United States |
$7.365B |
0.00 |
| Repligen (RGEN) |
United States |
$7.107B |
79.56 |
| Bio-Rad Laboratories, Inc. (BIO.B) |
US |
$6.805B |
23.68 |
| Jazz Pharmaceuticals PLC (JAZZ) |
IE |
$6.717B |
6.48 |
| Blueprint Medicines Corporation (BPMC) |
US |
$6.567B |
0.00 |
| Halozyme Therapeutics, Inc. (HALO) |
US |
$6.410B |
12.27 |
| Verona Pharma American Depositary Share (VRNA) |
United Kingdom |
$6.060B |
0.00 |
| Telix Pharmaceuticals (TLX) |
Australia |
$5.637B |
0.00 |
| TG Therapeutics (TGTX) |
United States |
$5.455B |
143.17 |
| Axsome Therapeutics, Inc. (AXSM) |
US |
$5.294B |
0.00 |
| Nuvalent (NUVL) |
United States |
$5.250B |
0.00 |
| Alkermes plc (ALKS) |
IE |
$5.181B |
13.90 |
| Regencell Bioscience Holdings (RGC) |
Hong Kong, SAR China |
$5.114B |
0.00 |
| Legend Biotech Corporation Sponsored ADR (LEGN) |
US |
$5.105B |
0.00 |
| Guardant Health, Inc. (GH) |
US |
$5.039B |
0.00 |
| ADMA Biologics Inc (ADMA) |
US |
$4.701B |
35.16 |
| Zealand Pharma (ZLDPF) |
Denmark |
$4.417B |
0.00 |
| Vaxcyte (PCVX) |
United States |
$4.109B |
0.00 |
| Rhythm Pharmaceuticals (RYTM) |
United States |
$3.813B |
0.00 |
| Krystal Biotech, Inc. (KRYS) |
US |
$3.774B |
29.09 |
| ACADIA Pharmaceuticals Inc. (ACAD) |
US |
$3.725B |
32.74 |
| Cytokinetics, Incorporated (CYTK) |
US |
$3.702B |
0.00 |
| Avidity Biosciences (RNA) |
United States |
$3.658B |
0.00 |
| PTC Therapeutics (PTCT) |
United States |
$3.647B |
6.35 |
| Sarepta Therapeutics (SRPT) |
United States |
$3.580B |
0.00 |
| SpringWorks Therapeutics (SWTX) |
United States |
$3.473B |
0.00 |
| Zai Lab (ZLAB) |
China |
$3.412B |
0.00 |
| Ultragenyx Pharmaceutical (RARE) |
United States |
$3.367B |
0.00 |
| CRISPR Therapeutics AG (CRSP) |
CH |
$3.348B |
0.00 |
| Arcellx, Inc. (ACLX) |
US |
$3.239B |
0.00 |
| Viking Therapeutics (VKTX) |
United States |
$3.193B |
0.00 |
| Alvotech (ALVO) |
LU |
$3.154B |
18.03 |
| Metsera Inc. (MTSR) |
US |
$3.101B |
0.00 |
| Akero Therapeutics, Inc. (AKRO) |
US |
$3.099B |
0.00 |
| Scholar Rock Holding (SRRK) |
United States |
$2.901B |
0.00 |
| Merus N.V. (MRUS) |
NL |
$2.877B |
0.00 |
| Protagonist Therapeutics (PTGX) |
United States |
$2.758B |
59.32 |
| ImmunityBio, Inc. (IBRX) |
US |
$2.507B |
0.00 |
| Immunovant, Inc. (IMVT) |
US |
$2.456B |
0.00 |
| MoonLake Immunotherapeutics (MLTX) |
CH |
$2.408B |
0.00 |
| HUTCHMED (China) Limited Sponsored ADR (HCM) |
HK |
$2.334B |
0.00 |
| Xenon Pharmaceuticals (XENE) |
Canada |
$2.324B |
0.00 |
| Mirum Pharmaceuticals, Inc. (MIRM) |
US |
$2.230B |
0.00 |
| Apellis Pharmaceuticals, Inc. (APLS) |
US |
$2.193B |
0.00 |
| Arrowhead Pharmaceuticals, Inc. (ARWR) |
US |
$2.170B |
0.00 |
| Vericel (VCEL) |
United States |
$2.139B |
1416.00 |
| Belite Bio, Inc. Sponsored ADR (BLTE) |
US |
$2.050B |
0.00 |
| Ligand Pharmaceuticals Incorporated (LGND) |
US |
$2.017B |
0.00 |
| Harmony Biosciences Holdings, Inc. (HRMY) |
US |
$2.014B |
13.39 |
| Denali Therapeutics Inc. (DNLI) |
US |
$2.002B |
0.00 |
| NovoCure (NVCR) |
Jersey |
$1.994B |
0.00 |
| Amicus Therapeutics, Inc. (FOLD) |
US |
$1.980B |
214.33 |
| Ascentage Pharma Group International - Unsponsored ADR (AAPG) |
CN |
$1.972B |
0.00 |
| Kymera Therapeutics, Inc. (KYMR) |
US |
$1.970B |
0.00 |
| Bavarian Nordic (BVNRY) |
DK |
$1.949B |
10.30 |
| CG Oncology, Inc. (CGON) |
US |
$1.938B |
0.00 |
| Certara, Inc. (CERT) |
US |
$1.927B |
36.00 |
| Kiniksa Pharmaceuticals, Ltd. (KNSA) |
GB |
$1.915B |
0.00 |
| Apogee Therapeutics Inc. (APGE) |
US |
$1.870B |
0.00 |
| Twist Bioscience (TWST) |
United States |
$1.853B |
0.00 |
| Tarsus Pharmaceuticals (TARS) |
United States |
$1.836B |
0.00 |
| Beam Therapeutics Inc. (BEAM) |
US |
$1.799B |
0.00 |
| Agios Pharmaceuticals, Inc. (AGIO) |
US |
$1.690B |
0.00 |
| Arcutis Biotherapeutics, Inc. (ARQT) |
US |
$1.682B |
0.00 |
| Disc Medicine, Inc. (IRON) |
US |
$1.666B |
0.00 |
| Biohaven Ltd. (BHVN) |
US |
$1.636B |
0.00 |
| Liquidia Technologies, Inc. (LQDA) |
US |
$1.614B |
0.00 |
| IDEAYA Biosciences, Inc. (IDYA) |
US |
$1.561B |
0.00 |
| Edgewise Therapeutics, Inc. (EWTX) |
US |
$1.555B |
0.00 |
| Immunocore Holdings PLC Sponsored ADR (IMCR) |
GB |
$1.521B |
0.00 |
| Mesoblast Limited (MESO) |
AU |
$1.498B |
0.00 |
| Travere Therapeutics (TVTX) |
United States |
$1.492B |
0.00 |
| Structure Therapeutics Inc. Sponsored ADR (GPCR) |
US |
$1.443B |
0.00 |
| Janux Therapeutics, Inc. (JANX) |
US |
$1.437B |
0.00 |
| GRAIL, Inc. (GRAL) |
US |
$1.436B |
0.00 |
| Adaptive Biotechnologies Corporation (ADPT) |
US |
$1.375B |
0.00 |
| Celldex Therapeutics, Inc. (CLDX) |
US |
$1.358B |
0.00 |
| Vera Therapeutics (VERA) |
United States |
$1.355B |
0.00 |
| MannKind Corporation (MNKD) |
US |
$1.328B |
27.31 |
| ANI Pharmaceuticals, Inc. (ANIP) |
US |
$1.300B |
13.39 |
| BGM Group Ltd. (BGM) |
CN |
$1.219B |
0.00 |
| Pacira BioSciences (PCRX) |
United States |
$1.197B |
11.39 |
| Dynavax Technologies Corporation (DVAX) |
US |
$1.161B |
69.07 |
| 89BIO (ETNB) |
US |
$1.135B |
0.00 |
| Novavax (NVAX) |
United States |
$1.090B |
2.54 |
| Anbio Biotechnology (NNNN) |
Germany |
$1.085B |
0.00 |
| Gyre Therapeutics, Inc. (GYRE) |
US |
$1.064B |
283.75 |
| Viridian Therapeutics (VRDN) |
United States |
$1.056B |
0.00 |
| NeoGenomics (NEO) |
United States |
$1.044B |
0.00 |
| MiMedx Group, Inc (MDXG) |
US |
$1.041B |
25.18 |
| Mineralys Therapeutics, Inc. (MLYS) |
US |
$1.000B |
0.00 |
| WAVE Life Sciences (WVE) |
Singapore |
$0.976B |
0.00 |
| Spyre Therapeutics (SYRE) |
United States |
$0.915B |
0.00 |
| Arcus Biosciences (RCUS) |
United States |
$0.906B |
0.00 |
| Intellia Therapeutics (NTLA) |
United States |
$0.880B |
0.00 |
| Pharvaris (PHVS) |
Netherlands |
$0.866B |
0.00 |
| Niagen Bioscience (NAGE) |
United States |
$0.863B |
121.67 |
| CureVac N.V. (CVAC) |
DE |
$0.835B |
4.54 |
| CorMedix Inc (CRMD) |
US |
$0.833B |
55.82 |
| Zymeworks (ZYME) |
United States |
$0.815B |
0.00 |
| Geron Corporation (GERN) |
US |
$0.809B |
0.00 |
| Bicara Therapeutics Inc. (BCAX) |
US |
$0.789B |
0.00 |
| Oculis Holding AG (OCS) |
Switzerland |
$0.779B |
0.00 |
| Syndax Pharmaceuticals (SNDX) |
United States |
$0.779B |
0.00 |
| Nuvation Bio (NUVB) |
United States |
$0.769B |
0.00 |
| LENZ Therapeutics, Inc. (LENZ) |
US |
$0.755B |
0.00 |
| Praxis Precision Medicines (PRAX) |
United States |
$0.754B |
0.00 |
| UniQure (QURE) |
Netherlands |
$0.750B |
0.00 |
| Nurix Therapeutics (NRIX) |
United States |
$0.729B |
0.00 |
| Anavex Life Sciences Corp. (AVXL) |
US |
$0.710B |
0.00 |
| Immunome, Inc. (IMNM) |
US |
$0.701B |
0.00 |
| Rocket Pharmaceuticals (RCKT) |
United States |
$0.694B |
0.00 |
| ArriVent BioPharma, Inc. (AVBP) |
US |
$0.662B |
0.00 |
| Trevi Therapeutics (TRVI) |
United States |
$0.649B |
0.00 |
| Sinovac Biotech (SVA) |
China |
$0.645B |
0.00 |
| Vir Biotechnology (VIR) |
United States |
$0.636B |
0.00 |
| Day One Biopharmaceuticals, Inc. (DAWN) |
US |
$0.634B |
0.00 |
| Pharming Group (PHAR) |
Netherlands |
$0.633B |
0.00 |
| Dianthus Therapeutics, Inc. (DNTH) |
US |
$0.633B |
0.00 |
| Basilea Pharmaceutica AG (BPMUF) |
CH |
$0.626B |
0.00 |
| Pharming Group (PHGUF) |
Netherlands |
$0.613B |
0.00 |
| AbCellera Biologics Inc. (ABCL) |
CA |
$0.606B |
0.00 |
| Replimune (REPL) |
United States |
$0.605B |
0.00 |
| AnaptysBio, Inc. (ANAB) |
US |
$0.594B |
0.00 |
| Sionna Therapeutics (SION) |
United States |
$0.593B |
0.00 |
| Arbutus Biopharma Corporation (ABUS) |
US |
$0.590B |
0.00 |
| Immatics N.V. (IMTX) |
DE |
$0.576B |
0.00 |
| Keros Therapeutics, Inc. (KROS) |
US |
$0.571B |
0.00 |
| GH Research PLC (GHRS) |
IE |
$0.571B |
0.00 |
| Bicycle Therapeutics PLC Sponsored ADR (BCYC) |
GB |
$0.561B |
0.00 |
| Cogent Biosciences, Inc. (COGT) |
US |
$0.556B |
0.00 |
| Iovance Biotherapeutics, Inc. (IOVA) |
US |
$0.554B |
0.00 |
| Stoke Therapeutics (STOK) |
United States |
$0.533B |
12.35 |
| Tyra Biosciences (TYRA) |
United States |
$0.530B |
0.00 |
| Opthea (OPT) |
Australia |
$0.525B |
0.00 |
| Kura Oncology, Inc. (KURA) |
US |
$0.521B |
0.00 |
| Eton Pharmaceuticals, Inc. (ETON) |
US |
$0.508B |
0.00 |
| Mind Medicine (MindMed) Inc. (MNMD) |
US |
$0.497B |
0.00 |
| Castle Biosciences, Inc. (CSTL) |
US |
$0.484B |
32.84 |
| Arvinas, Inc. (ARVN) |
US |
$0.474B |
0.00 |
| Upstream Bio (UPB) |
United States |
$0.465B |
0.00 |
| Ginkgo Bioworks Holdings, Inc. (DNA) |
US |
$0.464B |
0.00 |
| REGENXBIO (RGNX) |
United States |
$0.446B |
0.00 |
| Cullinan Therapeutics, Inc. (CGEM) |
US |
$0.443B |
0.00 |
| Septerna (SEPN) |
United States |
$0.438B |
0.00 |
| Zenas BioPharma (ZBIO) |
United States |
$0.438B |
0.00 |
| Precigen (PGEN) |
United States |
$0.428B |
0.00 |
| EYEPOINT PHARMACEUTICALS, INC. (EYPT) |
US |
$0.422B |
0.00 |
| Verastem (VSTM) |
United States |
$0.417B |
0.00 |
| Northwest Biotherapeutics (NWBO) |
United States |
$0.417B |
0.00 |
| Oxford BioMedica (OXBDF) |
United Kingdom |
$0.416B |
0.00 |
| Maze Therapeutics, Inc. (MAZE) |
US |
$0.405B |
0.00 |
| Fortrea Holdings Inc. (FTRE) |
US |
$0.402B |
11.10 |
| Celcuity, Inc. (CELC) |
US |
$0.402B |
0.00 |
| MeiraGTx Holdings PLC (MGTX) |
US |
$0.401B |
0.00 |
| Kamada Ltd. (KMDA) |
IL |
$0.399B |
23.93 |
| PureTech Health (PRTC) |
United States |
$0.398B |
0.00 |
| Sana Biotechnology (SANA) |
United States |
$0.393B |
0.00 |
| Tectonic Therapeutic (TECX) |
United States |
$0.392B |
0.00 |
| Prothena (PRTA) |
Ireland |
$0.386B |
0.00 |
| Abivax SA Sponsored ADR (ABVX) |
FR |
$0.381B |
0.00 |
| Myriad Genetics, Inc. (MYGN) |
US |
$0.381B |
0.00 |
| MBX Biosciences, Inc. (MBX) |
US |
$0.373B |
0.00 |
| Fulcrum Therapeutics, Inc. (FULC) |
US |
$0.371B |
0.00 |
| Zhengye Biotechnology Holding (ZYBT) |
China |
$0.370B |
0.00 |
| Absci Corporation (ABSI) |
US |
$0.367B |
0.00 |
| Erasca, Inc. (ERAS) |
US |
$0.364B |
0.00 |
| Rapport Therapeutics (RAPP) |
United States |
$0.364B |
0.00 |
| Emergent Biosolutions Inc. (EBS) |
US |
$0.360B |
0.00 |
| Mereo BioPharma Group plc - Sponsored ADR (MREO) |
GB |
$0.356B |
0.00 |
| Autolus Therapeutics PLC Sponsored ADR (AUTL) |
GB |
$0.354B |
0.00 |
| Alpha Teknova (TKNO) |
United States |
$0.354B |
0.00 |
| Benitec Biopharma Limited (BNTC) |
US |
$0.348B |
0.00 |
| Checkpoint Therapeutics, Inc. (CKPT) |
US |
$0.348B |
0.00 |
| Humacyte, Inc. (HUMA) |
US |
$0.347B |
0.00 |
| Cytek Biosciences, Inc. (CTKB) |
US |
$0.338B |
0.00 |
| Urogen Pharma (URGN) |
United States |
$0.337B |
0.00 |
| Oric Pharmaceuticals (ORIC) |
United States |
$0.336B |
0.00 |
| XOMA Royalty (XOMA) |
United States |
$0.323B |
0.00 |
| Olema Pharmaceuticals (OLMA) |
United States |
$0.322B |
0.00 |
| Cidara Therapeutics, Inc. (CDTX) |
US |
$0.320B |
0.00 |
| Arcturus Therapeutics Holdings Inc. (ARCT) |
US |
$0.316B |
0.00 |
| Abeona Therapeutics Inc. (ABEO) |
US |
$0.312B |
0.00 |
| Entrada Therapeutics (TRDA) |
United States |
$0.307B |
9.99 |
| DBV Technologies S.A. (DBVT) |
FR |
$0.304B |
0.00 |
| Aura Biosciences, Inc. (AURA) |
US |
$0.299B |
0.00 |
| iTeos Therapeutics, Inc. (ITOS) |
US |
$0.299B |
0.00 |
| Prima BioMed Ltd (IMMP) |
AU |
$0.296B |
0.00 |
| aTyr Pharma, Inc. (ATYR) |
US |
$0.291B |
0.00 |
| Compass Therapeutics, Inc. (CMPX) |
US |
$0.290B |
0.00 |
| Phathom Pharmaceuticals (PHAT) |
United States |
$0.285B |
0.00 |
| Candel Therapeutics, Inc. (CADL) |
US |
$0.268B |
0.00 |
| Cartesian Therapeutics (RNAC) |
United States |
$0.266B |
0.00 |
| 2seventy Bio (TSVT) |
United States |
$0.266B |
0.00 |
| Alumis Inc. (ALMS) |
US |
$0.265B |
0.00 |
| Neurogene (NGNE) |
United States |
$0.257B |
0.00 |
| Lifecore Biomedical, Inc. (LFCR) |
US |
$0.255B |
0.00 |
| Inozyme Pharma, Inc. (INZY) |
US |
$0.255B |
0.00 |
| Terns Pharmaceuticals (TERN) |
United States |
$0.252B |
0.00 |
| Foghorn Therapeutics Inc. (FHTX) |
US |
$0.247B |
0.00 |
| Corvus Pharmaceuticals, Inc. (CRVS) |
US |
$0.246B |
0.00 |
| Vanda Pharmaceuticals (VNDA) |
United States |
$0.245B |
0.00 |
| Monte Rosa Therapeutics, Inc. (GLUE) |
US |
$0.245B |
49.75 |
| MaxCyte, Inc. (MXCT) |
US |
$0.245B |
0.00 |
| Palvella Therapeutics (PVLA) |
United States |
$0.244B |
0.00 |
| Allogene Therapeutics, Inc. (ALLO) |
US |
$0.243B |
0.00 |
| Gossamer Bio, Inc. (GOSS) |
US |
$0.236B |
0.00 |
| Atea Pharmaceuticals, Inc. (AVIR) |
US |
$0.234B |
0.00 |
| Third Harmonic Bio (THRD) |
United States |
$0.234B |
0.00 |
| Bright Minds Biosciences Inc. (DRUG) |
US |
$0.232B |
0.00 |
| Monopar Therapeutics Inc. (MNPR) |
US |
$0.227B |
0.00 |
| ACELYRIN, INC (SLRN) |
United States |
$0.227B |
0.00 |
| Astria Therapeutics, Inc. (ATXS) |
US |
$0.223B |
0.00 |
| Ocugen (OCGN) |
United States |
$0.221B |
0.00 |
| Annexon, Inc. (ANNX) |
US |
$0.221B |
0.00 |
| Amarin Corporation PLC (AMRN) |
IE |
$0.219B |
0.00 |
| Rezolute (RZLT) |
United States |
$0.216B |
0.00 |
| Solid Biosciences (SLDB) |
United States |
$0.215B |
0.00 |
| Aardvark Therapeutics, Inc. (AARD) |
US |
$0.215B |
0.00 |
| Adocia (ADOCY) |
FR |
$0.213B |
0.00 |
| GENFIT S.A. Unsponsored ADR (GNFT) |
FR |
$0.209B |
0.00 |
| Prime Medicine (PRME) |
United States |
$0.209B |
0.00 |
| Semper Paratus Acquisition (TVGN) |
United States |
$0.208B |
0.00 |
| Actuate Therapeutics, Inc. (ACTU) |
US |
$0.207B |
0.00 |
| BioStem Technologies, Inc. (BSEM) |
|
$0.207B |
8.43 |
| Nuvectis Pharma (NVCT) |
United States |
$0.206B |
0.00 |
| Codexis, Inc. (CDXS) |
US |
$0.205B |
0.00 |
| Design Therapeutics, Inc. (DSGN) |
US |
$0.199B |
0.00 |
| Innate Pharma S.A. Sponsored ADR (IPHA) |
FR |
$0.194B |
0.00 |
| Lexicon Pharmaceuticals, Inc. (LXRX) |
US |
$0.193B |
0.00 |
| CARGO Therapeutics, Inc. (CRGX) |
US |
$0.190B |
0.00 |
| Adherex Technologies Inc. (FENC) |
US |
$0.189B |
0.00 |
| ADC Therapeutics SA (ADCT) |
CH |
$0.187B |
0.00 |
| Cardiff Oncology, Inc. (CRDF) |
US |
$0.187B |
0.00 |
| Y-mAbs Therapeutics (YMAB) |
United States |
$0.186B |
0.00 |
| Kodiak Sciences Inc. (KOD) |
US |
$0.185B |
0.00 |
| Voyager Therapeutics (VYGR) |
United States |
$0.183B |
0.00 |
| INmune Bio, Inc. (INMB) |
US |
$0.181B |
0.00 |
| DiaMedica Therapeutics, Inc. (DMAC) |
US |
$0.180B |
0.00 |
| Inhibrx Biosciences, Inc. (INBX) |
US |
$0.178B |
0.11 |
| enGene Holdings Inc. (ENGN) |
CA |
$0.176B |
0.00 |
| Anika Therapeutics Inc. (ANIK) |
US |
$0.175B |
0.00 |
| Eledon Pharmaceuticals, Inc. (ELDN) |
US |
$0.172B |
0.00 |
| AC Immune (ACIU) |
CH |
$0.172B |
0.00 |
| TuHURA Biosciences, Inc. (HURA) |
US |
$0.171B |
0.00 |
| ProQR Therapeutics (PRQR) |
Netherlands |
$0.170B |
0.00 |
| ScPharmaceuticals (SCPH) |
United States |
$0.170B |
0.00 |
| Puma Biotechnology (PBYI) |
United States |
$0.168B |
4.40 |
| CytomX Therapeutics, Inc. (CTMX) |
US |
$0.164B |
4.23 |
| Inventiva S.A. Sponsored ADR (IVA) |
FR |
$0.163B |
0.00 |
| Galena Biopharma (SLS) |
United States |
$0.163B |
0.00 |
| Tango Therapeutics (TNGX) |
United States |
$0.163B |
0.00 |
| Tiziana Life Sciences (TLSA) |
United Kingdom |
$0.159B |
0.00 |
| Molecular Partners AG Sponsored ADR (MOLN) |
CH |
$0.155B |
0.00 |
| BioAge Labs, Inc. (BIOA) |
US |
$0.141B |
0.00 |
| Alpha Cognition Inc. (ACOG) |
CA |
$0.139B |
0.00 |
| Eupraxia Pharmaceuticals Inc. (EPRX) |
CA |
$0.138B |
0.00 |
| Greenwich LifeSciences, Inc. (GLSI) |
US |
$0.129B |
0.00 |
| Editas Medicine, Inc. (EDIT) |
US |
$0.126B |
0.00 |
| eXoZymes Inc. (EXOZ) |
US |
$0.126B |
0.00 |
| Compugen Ltd. (CGEN) |
IL |
$0.124B |
0.00 |
| Seer (SEER) |
United States |
$0.124B |
0.00 |
| Nkarta (NKTX) |
United States |
$0.123B |
0.00 |
| Fate Therapeutics, Inc. (FATE) |
US |
$0.123B |
0.00 |
| Alector, Inc. (ALEC) |
US |
$0.122B |
0.00 |
| Theratechnologies (THTX) |
Canada |
$0.120B |
0.00 |
| Vigil Neuroscience (VIGL) |
United States |
$0.116B |
0.00 |
| Neumora Therapeutics (NMRA) |
United States |
$0.113B |
0.00 |
| InflaRx N.V. (IFRX) |
DE |
$0.111B |
0.00 |
| Orchestra BioMed Holdings (OBIO) |
United States |
$0.111B |
0.00 |
| Rapt Therapeutics (RAPT) |
United States |
$0.111B |
0.00 |
| Black Diamond Therapeutics, Inc. (BDTX) |
US |
$0.111B |
32.50 |
| Sangamo Therapeutics (SGMO) |
United States |
$0.110B |
0.00 |
| BioHarvest Sciences Inc. (BHST) |
CA |
$0.107B |
0.00 |
| Nautilus Biotechnology (NAUT) |
United States |
$0.104B |
0.00 |
| Cabaletta Bio, Inc. (CABA) |
US |
$0.103B |
0.00 |
| Kyverna Therapeutics, Inc. (KYTX) |
US |
$0.100B |
0.00 |
| Ventyx Biosciences (VTYX) |
United States |
$0.100B |
0.00 |
| Coya Therapeutics, Inc. (COYA) |
US |
$0.099B |
0.00 |
| HilleVax, Inc. (HLVX) |
US |
$0.099B |
0.00 |
| Sagimet Biosciences (SGMT) |
United States |
$0.099B |
0.00 |
| C4 Therapeutics, Inc. (CCCC) |
US |
$0.098B |
0.00 |
| Instil Bio (TIL) |
United States |
$0.096B |
0.00 |
| Agenus Inc. (AGEN) |
US |
$0.095B |
0.00 |
| Cuprina Holdings (Cayman) Limited (CUPR) |
SG |
$0.094B |
0.00 |
| Genelux Corporation (GNLX) |
US |
$0.094B |
0.00 |
| Invivyd, Inc. (IVVD) |
US |
$0.093B |
0.00 |
| XBiotech (XBIT) |
United States |
$0.093B |
0.00 |
| Entera Bio Ltd. (ENTX) |
IL |
$0.092B |
0.00 |
| Immunic, Inc. (IMUX) |
US |
$0.092B |
0.00 |
| Medicus Pharma Ltd (MDCX) |
US |
$0.091B |
0.00 |
| Contineum Therapeutics, Inc. (CTNM) |
US |
$0.091B |
0.00 |
| Zentalis Pharmaceuticals (ZNTL) |
United States |
$0.091B |
0.00 |
| Coherus BioSciences, Inc. (CHRS) |
US |
$0.088B |
0.00 |
| Cellectis S.A. (CLLS) |
FR |
$0.088B |
0.00 |
| Caribou Biosciences, Inc. (CRBU) |
US |
$0.087B |
0.00 |
| Climb Bio, Inc. (CLYM) |
US |
$0.087B |
0.00 |
| Applied Therapeutics Inc. (APLT) |
US |
$0.085B |
0.00 |
| ANIXA BIOSCIENCES INC (ANIX) |
US |
$0.085B |
0.00 |
| Elicio Therapeutics, Inc. (ELTX) |
US |
$0.085B |
0.00 |
| Pliant Therapeutics (PLRX) |
United States |
$0.085B |
0.00 |
| Adagene Inc. Sponsored ADR (ADAG) |
CN |
$0.083B |
0.00 |
| Senti Biosciences (SNTI) |
United States |
$0.083B |
0.00 |
| Tvardi Therapeutics (TVRD) |
United States |
$0.079B |
0.00 |
| Genenta Science S.p.A. Unsponsored ADR (GNTA) |
IT |
$0.078B |
0.00 |
| Sutro Biopharma (STRO) |
United States |
$0.077B |
0.00 |
| Prenetics Global (PRE) |
Hong Kong, SAR China |
$0.077B |
0.00 |
| CervoMed Inc. (CRVO) |
US |
$0.076B |
0.00 |
| Zura Bio (ZURA) |
United States |
$0.076B |
0.00 |
| Inovio Pharmaceuticals, Inc. (INO) |
US |
$0.075B |
0.00 |
| Jasper Therapeutics, Inc. (JSPR) |
US |
$0.074B |
0.00 |
| I-Mab Sponsored ADR (IMAB) |
US |
$0.073B |
0.00 |
| Tenaya Therapeutics (TNYA) |
United States |
$0.073B |
0.00 |
| Adaptimmune Therapeutics PLC (ADAP) |
GB |
$0.073B |
0.00 |
| VistaGen Therapeutics (VTGN) |
United States |
$0.071B |
0.00 |
| IGM Biosciences, Inc. (IGMS) |
US |
$0.071B |
0.00 |
| TScan Therapeutics (TCRX) |
United States |
$0.070B |
0.00 |
| Elutia Inc. (ELUT) |
US |
$0.070B |
0.00 |
| ZIVO Bioscience (ZIVO) |
United States |
$0.069B |
0.00 |
| Alto Neuroscience, Inc. (ANRO) |
US |
$0.068B |
0.00 |
| Clearside Biomedical, Inc. (CLSD) |
US |
$0.068B |
0.00 |
| Adlai Nortye Ltd. Sponsored ADR (ANL) |
KY |
$0.068B |
0.00 |
| VTv Therapeutics (VTVT) |
United States |
$0.067B |
0.00 |
| BeyondSpring Inc. (BYSI) |
US |
$0.067B |
0.00 |
| Milestone Pharmaceuticals Inc. (MIST) |
CA |
$0.065B |
0.00 |
| Seres Therapeutics, Inc. (MCRB) |
US |
$0.065B |
0.00 |
| PDS Biotechnology (PDSB) |
United States |
$0.065B |
0.00 |
| Acumen Pharmaceuticals, Inc. (ABOS) |
US |
$0.065B |
0.00 |
| MediciNova, Inc. (MNOV) |
US |
$0.065B |
0.00 |
| Citius Oncology, Inc. (CTOR) |
US |
$0.065B |
0.00 |
| IO Biotech, Inc. (IOBT) |
DK |
$0.065B |
0.00 |
| Adicet Bio, Inc. (ACET) |
US |
$0.064B |
0.00 |
| Exicure (XCUR) |
United States |
$0.064B |
0.00 |
| Achilles Therapeutics PLC Sponsored ADR (ACHL) |
GB |
$0.061B |
0.00 |
| Skye Bioscience (SKYE) |
United States |
$0.058B |
0.00 |
| Repare Therapeutics (RPTX) |
Canada |
$0.057B |
0.00 |
| Immix Biopharma, Inc. (IMMX) |
US |
$0.057B |
0.00 |
| Biomea Fusion, Inc. (BMEA) |
US |
$0.057B |
0.00 |
| Oncobiologics (OTLK) |
United States |
$0.057B |
0.00 |
| Cue Biopharma, Inc. (CUE) |
US |
$0.055B |
0.00 |
| Ikena Oncology, Inc. (IKNA) |
US |
$0.054B |
0.00 |
| Fortress Biotech, Inc. (FBIO) |
US |
$0.054B |
0.00 |
| Shattuck Labs (STTK) |
United States |
$0.053B |
0.00 |
| Precision BioSciences, Inc. (DTIL) |
US |
$0.052B |
0.00 |
| Immuneering Corporation (IMRX) |
US |
$0.052B |
0.00 |
| Forte Biosciences, Inc. (FBRX) |
US |
$0.052B |
0.00 |
| Akoya Biosciences, Inc. (AKYA) |
US |
$0.051B |
0.00 |
| Renovaro (RENB) |
United States |
$0.051B |
0.00 |
| PepGen (PEPG) |
United States |
$0.050B |
0.00 |
| OKYO Pharma (OKYO) |
|
$0.050B |
0.00 |
| Earth Science Tech, Inc. (ETST) |
US |
$0.050B |
0.00 |
| Werewolf Therapeutics, Inc. (HOWL) |
US |
$0.050B |
0.00 |
| Artiva Biotherapeutics, Inc. (ARTV) |
US |
$0.049B |
0.00 |
| Rein Therapeutics (RNTX) |
United States |
$0.049B |
0.00 |
| bluebird bio, Inc. (BLUE) |
US |
$0.049B |
0.00 |
| Celularity, Inc. (CELU) |
US |
$0.049B |
0.00 |
| Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) |
GB |
$0.047B |
0.00 |
| Opus Genetics, Inc. (IRD) |
US |
$0.046B |
0.00 |
| CAMP4 Therapeutics Corporation (CAMP) |
US |
$0.046B |
0.00 |
| Xilio Therapeutics (XLO) |
United States |
$0.045B |
0.00 |
| Adverum Biotechnologies, Inc. (ADVM) |
US |
$0.044B |
0.00 |
| TELA Bio (TELA) |
United States |
$0.044B |
0.00 |
| RenovoRx (RNXT) |
United States |
$0.043B |
0.00 |
| Whitehawk Therapeutics (WHWK) |
United States |
$0.042B |
0.00 |
| Mersana Therapeutics, Inc. (MRSN) |
US |
$0.042B |
0.00 |
| Anebulo Pharmaceuticals, Inc. (ANEB) |
US |
$0.042B |
0.00 |
| Connect Biopharma Holdings Limited Sponsored ADR (CNTB) |
US |
$0.042B |
0.00 |
| Kronos Bio, Inc. (KRON) |
US |
$0.042B |
0.00 |
| Akari Therapeutics PLC (AKTX) |
GB |
$0.041B |
0.00 |
| Pluri (PLUR) |
Israel |
$0.041B |
0.00 |
| Atara Biotherapeutics, Inc. (ATRA) |
US |
$0.041B |
0.00 |
| Oncolytics Biotech (ONCY) |
Canada |
$0.040B |
0.00 |
| Quince Therapeutics (QNCX) |
United States |
$0.039B |
0.00 |
| Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) |
GB |
$0.038B |
0.00 |
| Boundless Bio, Inc. (BOLD) |
US |
$0.037B |
0.00 |
| Rani Therapeutics Holdings (RANI) |
United States |
$0.037B |
0.00 |
| AN2 Therapeutics, Inc. (ANTX) |
US |
$0.037B |
0.00 |
| Spero Therapeutics (SPRO) |
United States |
$0.036B |
0.00 |
| Lantern Pharma Inc. (LTRN) |
US |
$0.036B |
0.00 |
| FibroBiologics Inc. (FBLG) |
US |
$0.036B |
0.00 |
| Aligos Therapeutics, Inc. (ALGS) |
US |
$0.036B |
0.00 |
| Alterity Therapeutics Limited - Sponsored ADR (ATHE) |
AU |
$0.035B |
0.00 |
| Annovis Bio, Inc. (ANVS) |
US |
$0.035B |
0.00 |
| Estrella Immunopharma, Inc. (ESLA) |
US |
$0.035B |
0.00 |
| Coeptis Therapeutics Holdings, Inc. (COEP) |
US |
$0.034B |
0.00 |
| LAVA Therapeutics N.V. (LVTX) |
NL |
$0.033B |
0.00 |
| Dyadic International Inc. (DYAI) |
US |
$0.031B |
0.00 |
| Radiopharm Theranostics - (RADX) |
Australia |
$0.031B |
0.00 |
| Cyclacel Pharmaceuticals, Inc. (CYCC) |
|
$0.031B |
0.00 |
| Cadrenal Therapeutics, Inc. (CVKD) |
US |
$0.030B |
0.00 |
| MiNK Therapeutics, Inc. (INKT) |
US |
$0.030B |
0.00 |
| Allakos (ALLK) |
United States |
$0.030B |
0.00 |
| Kezar Life Sciences, Inc. (KZR) |
US |
$0.030B |
0.00 |
| Scilex Holding (SCLX) |
United States |
$0.029B |
0.00 |
| Femasys Inc. (FEMY) |
US |
$0.029B |
0.00 |
| Grace Therapeutics, Inc. (GRCE) |
CA |
$0.028B |
0.00 |
| CalciMedica Inc. (CALC) |
US |
$0.028B |
0.00 |
| Quantum Biopharma (QNTM) |
Canada |
$0.028B |
0.00 |
| Advanced Biomed Inc. (ADVB) |
US |
$0.027B |
0.00 |
| OnKure Therapeutics (OKUR) |
United States |
$0.027B |
0.00 |
| Dare Bioscience, Inc. (DARE) |
US |
$0.026B |
0.00 |
| Generation Bio Co. (GBIO) |
US |
$0.026B |
0.00 |
| ABVC BioPharma, Inc. (ABVC) |
US |
$0.025B |
0.00 |
| MIRA Pharmaceuticals, Inc. (MIRA) |
US |
$0.025B |
0.00 |
| Tenax Therapeutics (TENX) |
United States |
$0.024B |
0.00 |
| KALA BIO, Inc. (KALA) |
US |
$0.024B |
0.00 |
| BioAtla, Inc. (BCAB) |
US |
$0.023B |
0.00 |
| ALX Oncology Holdings Inc. (ALXO) |
US |
$0.023B |
0.00 |
| Clene Inc. (CLNN) |
US |
$0.023B |
0.00 |
| Lisata Therapeutics, Inc. (LSTA) |
US |
$0.023B |
0.00 |
| Vor Biopharma (VOR) |
|
$0.022B |
0.00 |
| Q32 Bio (QTTB) |
United States |
$0.022B |
0.00 |
| Ovid Therapeutics (OVID) |
United States |
$0.022B |
0.00 |
| Curis, Inc. (CRIS) |
US |
$0.021B |
0.00 |
| Longeveron Inc. (LGVN) |
US |
$0.021B |
0.00 |
| Cognition Therapeutics, Inc. (CGTX) |
US |
$0.020B |
0.00 |
| CollPlant Biotechnologies Ltd. Sponsored ADR (CLGN) |
IL |
$0.020B |
0.00 |
| Chemomab Therapeutics Ltd. Sponsored ADR (CMMB) |
IL |
$0.020B |
0.00 |
| HOOKIPA Pharma Inc. (HOOK) |
US |
$0.019B |
0.00 |
| Passage Bio (PASG) |
United States |
$0.019B |
0.00 |
| NeuroSense Therapeutics (NRSN) |
Israel |
$0.018B |
0.00 |
| Gelteq Limited (GELS) |
AU |
$0.018B |
0.00 |
| Lexaria Bioscience Corp. (LEXX) |
CA |
$0.018B |
0.00 |
| Kalaris Therapeutics Inc. (KLRS) |
US |
$0.018B |
0.00 |
| SAB Biotherapeutics (SABS) |
United States |
$0.017B |
0.00 |
| X4 Pharmaceuticals (XFOR) |
United States |
$0.017B |
0.00 |
| Promis Neurosciences (PMN) |
Canada |
$0.017B |
0.00 |
| Elevation Oncology, Inc. (ELEV) |
US |
$0.017B |
0.00 |
| Leap Therapeutics, Inc. (LPTX) |
US |
$0.017B |
0.00 |
| Cingulate Inc. (CING) |
US |
$0.016B |
0.00 |
| Beyond Air (XAIR) |
United States |
$0.016B |
0.00 |
| Allarity Therapeutics, Inc. (ALLR) |
US |
$0.016B |
0.00 |
| GeoVax Labs Inc. (GOVX) |
US |
$0.015B |
0.00 |
| Rallybio (RLYB) |
United States |
$0.015B |
0.00 |
| Edesa Biotech, Inc. (EDSA) |
CA |
$0.014B |
0.00 |
| UNITY Biotechnology (UBX) |
United States |
$0.014B |
0.00 |
| Equillium, Inc. (EQ) |
US |
$0.013B |
0.00 |
| Moleculin Biotech, Inc. (MBRX) |
US |
$0.013B |
0.00 |
| iBio, Inc. (IBIO) |
US |
$0.013B |
0.00 |
| Aytu BioPharma Inc. (AYTU) |
US |
$0.013B |
0.00 |
| HCW Biologics Inc. (HCWB) |
US |
$0.013B |
0.00 |
| Bionano Genomics, Inc. (BNGO) |
US |
$0.013B |
0.00 |
| BioCardia, Inc. (BCDA) |
US |
$0.013B |
0.00 |
| Synlogic (SYBX) |
United States |
$0.013B |
0.00 |
| NextCure (NXTC) |
United States |
$0.012B |
0.00 |
| Aspire Biopharma Holdings, Inc. (ASBP) |
US |
$0.012B |
0.00 |
| Biorestorative Therapies, Inc. (BRTX) |
US |
$0.012B |
0.00 |
| Abpro Holdings Inc. (ABP) |
US |
$0.012B |
0.00 |
| IN8bio, Inc. (INAB) |
US |
$0.012B |
0.00 |
| Hoth Therapeutics, Inc. (HOTH) |
US |
$0.011B |
0.00 |
| COSCIENS Biopharma Inc. (CSCI) |
CA |
$0.011B |
0.00 |
| Bolt Biotherapeutics, Inc. (BOLT) |
US |
$0.011B |
0.00 |
| BRIACELL THERAP (BCTX) |
CA |
$0.011B |
0.00 |
| Athira Pharma, Inc. (ATHA) |
US |
$0.011B |
0.00 |
| Brainstorm Cell Therapeutics Inc. (BCLI) |
US |
$0.010B |
0.00 |
| Aprea Therapeutics, Inc. (APRE) |
US |
$0.010B |
0.00 |
| Dogwood Therapeutics, Inc (DWTX) |
US |
$0.010B |
0.00 |
| IMMURON (IMRN) |
AU |
$0.010B |
0.00 |
| LakeShore Biopharma Co., Ltd. (LSB) |
CN |
$0.010B |
0.00 |
| Cyclerion Therapeutics, Inc. (CYCN) |
US |
$0.010B |
0.00 |
| Acurx Pharmaceuticals, Inc. (ACXP) |
US |
$0.009B |
0.00 |
| BioXcel Therapeutics, Inc. (BTAI) |
US |
$0.009B |
0.00 |
| Sensei Biotherapeutics (SNSE) |
United States |
$0.009B |
0.00 |
| Neuphoria Therapeutics (NEUP) |
Australia |
$0.009B |
0.00 |
| Imunon, Inc. (IMNN) |
US |
$0.008B |
0.00 |
| Portage Biotech (PRTG) |
|
$0.008B |
0.00 |
| Silexion Therapeutics Corp (SLXN) |
Israel |
$0.008B |
0.00 |
| Turnstone Biologics (TSBX) |
United States |
$0.008B |
0.00 |
| Intensity Therapeutics Inc. (INTS) |
US |
$0.008B |
0.00 |
| Avalon GloboCare Corp. (ALBT) |
US |
$0.007B |
0.00 |
| Evogene Ltd. (EVGN) |
IL |
$0.007B |
0.00 |
| GENPREX (GNPX) |
US |
$0.007B |
0.00 |
| 180 Life Sciences Corp. (ATNF) |
US |
$0.007B |
0.00 |
| Cardio Diagnostics Holdings, Inc. (CDIO) |
US |
$0.007B |
0.00 |
| Jade Biosciences, Inc. (JBIO) |
US |
$0.006B |
0.00 |
| Biofrontera Inc. (BFRI) |
US |
$0.006B |
0.00 |
| Soligenix (SNGX) |
United States |
$0.006B |
0.00 |
| MetaVia Inc. (MTVA) |
US |
$0.006B |
0.00 |
| GT Biopharma, Inc. (GTBP) |
US |
$0.006B |
0.00 |
| Mainz Biomed (MYNZ) |
Germany |
$0.006B |
0.00 |
| Lipella Pharmaceuticals Inc. (LIPO) |
US |
$0.006B |
0.00 |
| Ensysce Biosciences, Inc. (ENSC) |
US |
$0.006B |
0.00 |
| Arcadia Biosciences (RKDA) |
United States |
$0.006B |
0.00 |
| Onconetix (ONCO) |
United States |
$0.005B |
0.00 |
| Apollomics Inc. (APLM) |
US |
$0.005B |
0.00 |
| Creative Medical Technology Holdings, Inc. (CELZ) |
US |
$0.005B |
0.00 |
| Adial Pharmaceuticals, Inc. (ADIL) |
US |
$0.005B |
0.00 |
| Dermata Therapeutics, Inc. (DRMA) |
US |
$0.005B |
0.00 |
| Affimed N.V. (AFMD) |
DE |
$0.004B |
0.00 |
| Titan Pharmaceuticals (TTNP) |
United States |
$0.004B |
0.00 |
| Sonnet BioTherapeutics Holdings (SONN) |
United States |
$0.004B |
0.00 |
| Sunshine Biopharma (SBFM) |
United States |
$0.004B |
0.00 |
| VivoSim Labs (VIVS) |
United States |
$0.004B |
0.00 |
| bioAffinity Technologies, Inc. (BIAF) |
US |
$0.004B |
0.00 |
| Galecto, Inc. (GLTO) |
DK |
$0.004B |
0.00 |
| CNS Pharmaceuticals, Inc. (CNSP) |
US |
$0.004B |
0.00 |
| Lixte Biotechnology Holdings, Inc. (LIXT) |
US |
$0.004B |
0.00 |
| Mustang Bio, Inc. (MBIO) |
US |
$0.004B |
0.00 |
| Novogen Limited (KZIA) |
AU |
$0.004B |
0.00 |
| Tharimmune (THAR) |
United States |
$0.004B |
0.00 |
| Virax Biolabs Group (VRAX) |
United Kingdom |
$0.003B |
0.00 |
| Palisade Bio (PALI) |
United States |
$0.003B |
0.00 |
| Enveric Biosciences, Inc. (ENVB) |
US |
$0.003B |
0.00 |
| GRI Bio, Inc. (GRI) |
US |
$0.003B |
0.00 |
| Eyenovia, Inc. (EYEN) |
US |
$0.003B |
0.00 |
| AquaBounty Technologies, Inc. (AQB) |
US |
$0.003B |
0.00 |
| Artelo Biosciences, Inc. (ARTL) |
US |
$0.003B |
0.00 |
| Purple Biotech (PPBT) |
Israel |
$0.003B |
0.00 |
| Windtree Therapeutics (WINT) |
United States |
$0.003B |
0.00 |
| Synaptogenix (SNPX) |
United States |
$0.003B |
0.00 |
| Psyence Biomedical (PBM) |
Canada |
$0.003B |
0.00 |
| Pasithea Therapeutics Corp. (KTTA) |
US |
$0.003B |
0.00 |
| Revelation Biosciences (REVB) |
United States |
$0.003B |
0.00 |
| Alzamend Neuro, Inc. (ALZN) |
US |
$0.003B |
0.00 |
| Scinai Immunotherapeutics (SCNI) |
Israel |
$0.003B |
0.00 |
| Aptevo Therapeutics Inc. (APVO) |
US |
$0.003B |
0.00 |
| Evaxion Biotech A/S Sponsored ADR (EVAX) |
DK |
$0.002B |
0.00 |
| Bone Biologics Corp. (BBLG) |
US |
$0.002B |
0.00 |
| Silo Pharma (SILO) |
United States |
$0.002B |
0.00 |
| Entero Therapeutics, Inc. (ENTO) |
US |
$0.002B |
0.00 |
| Atrinsic (PTIX) |
United States |
$0.002B |
0.00 |
| ZyVersa Therapeutics (ZVSA) |
United States |
$0.001B |
0.00 |
| Capstone Therapeutics Corp. (CAPS) |
US |
$0.000B |
0.00 |
| TFF Pharmaceuticals (TFFP) |
United States |
$0.000B |
0.00 |
| NuCana (NCNA) |
United Kingdom |
$0.000B |
0.00 |
| Polyrizon (PLRZ) |
Israel |
$0.000B |
0.00 |
| Aceragen, Inc. (ACGN) |
US |
$0.000B |
0.00 |
| ARAVIVE, INC (ARAV) |
US |
$0.000B |
0.00 |
| Clovis Oncology, Inc. (CLVSQ) |
US |
$0.000B |
0.00 |
| Cocrystal Pharma, Inc. (COCP) |
US |
$0.000B |
0.00 |
| Celyad SA (CYAD) |
BE |
$0.000B |
0.00 |
| CytoMed Therapeutics Limited (GDTC) |
SG |
$0.000B |
0.00 |
| Galapagos NV (GLPG) |
BE |
$0.000B |
0.00 |
| Motif Bio Plc (MTFB) |
GB |
$0.000B |
0.00 |
| PDL BioPharma (PDLI) |
United States |
$0.000B |
0.00 |
| Pulmatrix (PULM) |
United States |
$0.000B |
0.00 |
| VectivBio Holding AG (VECT) |
Switzerland |
$0.000B |
0.00 |
